Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study

Key Points

Evaluate the prognostic value of an RNA expression signature derived from cell cycle proliferation genes in individuals diagnosed with prostate cancer.
Retrospective analysis investigating RNA expression levels of cell cycle proliferation genes in prostate cancer patient samples.
The cell cycle proliferation gene expression signature provides significant prognostic information regarding clinical outcomes in prostate cancer.

Answers are grounded in this paper and cite their sources.

Retrospective study demonstrates prognostic utility of a cell cycle gene signature in prostate cancer, highlighting improved risk assessment.

Cancer Research UK, Queen Mary University of London, Orchid Appeal, US National Institutes of Health, and Koch Foundation.

No takes yet. Share an insight, caveat, or question.

Cuzick et al. (2011) studied this question.

View Full Paper

Ask AI

Bookmark

Share